SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010290
Filing Date
2019-11-07
Accepted
2019-11-07 08:26:29
Documents
54
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20190930x10q.htm 10-Q 1396829
2 EX-31.1 glyc-20190930ex3119e81f9.htm EX-31.1 18164
3 EX-31.2 glyc-20190930ex312e9376e.htm EX-31.2 17241
4 EX-32.1 glyc-20190930ex32158b2e4.htm EX-32.1 10303
  Complete submission text file 0001558370-19-010290.txt   4773627

Data Files

Seq Description Document Type Size
5 EX-101.INS glyc-20190930.xml EX-101.INS 903252
6 EX-101.SCH glyc-20190930.xsd EX-101.SCH 31249
7 EX-101.CAL glyc-20190930_cal.xml EX-101.CAL 39202
8 EX-101.DEF glyc-20190930_def.xml EX-101.DEF 135123
9 EX-101.LAB glyc-20190930_lab.xml EX-101.LAB 309493
10 EX-101.PRE glyc-20190930_pre.xml EX-101.PRE 250910
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 191198242
SIC: 2834 Pharmaceutical Preparations